Fluxus

Sunnyvale, United States

Fluxus develops biochip detection platforms for sensitivity diagnostics and bioanalytical applications.

$4.7M raised

Apr 2025

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Fluxus raised?

Fluxus has raised $4.7M in total funding. The most recent round was Grant. The last funding was announced in April 2025.

Who are Fluxus's investors?

Fluxus's investors include Global Health Innovative Technology Fund.

Where is Fluxus headquartered?

Fluxus is headquartered in Sunnyvale, United States.

What does Fluxus do?

Fluxus develops biochip detection platforms for sensitivity diagnostics and bioanalytical applications.

What stage is Fluxus at?

Fluxus is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 23, 2025.

MLA

"Fluxus — Funding & Investors." VCBacked, April 23, 2025, https://www.vcbacked.co/company/fluxus. Accessed July 2, 2026.

APA

VCBacked. (2025). Fluxus — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/fluxus

Wikipedia (cite web)

{{cite web |title=Fluxus — Funding & Investors |url=https://www.vcbacked.co/company/fluxus |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 23, 2025.